Kilian Garrec

Title: Kilian Garrec: Innovator in Glucocorticoid Receptor Modulators

Introduction

Kilian Garrec is a notable inventor based in Menlo Park, California. He has made significant contributions to the field of medicinal chemistry, particularly in the development of glucocorticoid receptor modulators. His innovative work has led to advancements in therapeutic methods that aim to improve health outcomes.

Latest Patents

Kilian Garrec holds a patent titled "Methods of preparing heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators." This invention provides methods for preparing these compounds, which are characterized by low impurity levels. His patent represents a significant step forward in the synthesis of effective glucocorticoid receptor modulators, with potential applications in various medical treatments. He has 1 patent to his name.

Career Highlights

Kilian Garrec is currently employed at Corcept Therapeutics Incorporated, a company known for its focus on developing innovative therapies for patients with serious medical conditions. His role at Corcept Therapeutics allows him to apply his expertise in medicinal chemistry to real-world challenges in healthcare.

Collaborations

Kilian has collaborated with notable colleagues, including Thomas C. Stephens and Adam Daisuke Gammack Yamagata. These collaborations have likely contributed to the advancement of his research and the successful development of his patented methods.

Conclusion

Kilian Garrec is a distinguished inventor whose work in glucocorticoid receptor modulators has the potential to impact the field of medicine significantly. His contributions, particularly through his patent, highlight the importance of innovation in developing effective therapeutic solutions.